Acquired by Carlyle Group
Tescan will experience aggressive cost-cutting measures, including deferring maintenance on analytical instruments and reducing R&D budgets for new product development
Tescan's advanced imaging technologies will likely see a decline in performance and reliability as older equipment is not properly serviced or upgraded
Customers relying on Tescan's analytical solutions may experience more frequent downtime, longer repair turnaround times, and reduced technical support
Announcements about 'operational efficiency' initiatives and 'optimizing the portfolio'
First rounds of staff reductions in R&D and technical support teams
Noticeable decline in instrument performance, increased service disruptions, and longer wait times for repairs
Potential product quality issues and complaints from Tescan's scientific and industrial customers
Increased risk of Tescan filing for bankruptcy or being sold off in a distressed acquisition
Customers relying on Tescan's products should closely monitor performance, reliability, and availability of technical support
Consider diversifying critical analytical instrumentation to mitigate risk of Tescan service disruptions
Advocate for Tescan to maintain R&D budgets and equipment maintenance schedules to preserve product quality
Look for family-owned or employee-owned businesses